Alkermes Plc (ALKS)
47.72
+0.52
(+1.10%)
USD |
NASDAQ |
Sep 02, 16:00
47.70
-0.02
(-0.04%)
After-Hours: 20:00
Alkermes Cash from Investing (Quarterly) : -2.411M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.411M |
| March 31, 2026 | -2.077B |
| December 31, 2025 | 322.35M |
| September 30, 2025 | -6.737M |
| June 30, 2025 | -29.21M |
| March 31, 2025 | 9.102M |
| December 31, 2024 | -13.88M |
| September 30, 2024 | -109.33M |
| June 30, 2024 | 51.85M |
| March 31, 2024 | -39.95M |
| December 31, 2023 | -20.98M |
| September 30, 2023 | -119.36M |
| June 30, 2023 | 120.85M |
| March 31, 2023 | 72.85M |
| December 31, 2022 | 27.74M |
| September 30, 2022 | 8.898M |
| June 30, 2022 | -40.54M |
| March 31, 2022 | -60.64M |
| December 31, 2021 | -0.742M |
| September 30, 2021 | -31.71M |
| June 30, 2021 | 3.977M |
| March 31, 2021 | -37.73M |
| December 31, 2020 | -35.10M |
| September 30, 2020 | -8.227M |
| June 30, 2020 | 14.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.49M |
| December 31, 2019 | -101.47M |
| September 30, 2019 | 31.59M |
| June 30, 2019 | -7.253M |
| March 31, 2019 | -64.70M |
| December 31, 2018 | -7.803M |
| September 30, 2018 | 26.15M |
| June 30, 2018 | -65.88M |
| March 31, 2018 | 25.34M |
| December 31, 2017 | -14.19M |
| September 30, 2017 | -13.60M |
| June 30, 2017 | -6.021M |
| March 31, 2017 | 15.46M |
| December 31, 2016 | -20.88M |
| September 30, 2016 | 46.99M |
| June 30, 2016 | 28.44M |
| March 31, 2016 | 72.69M |
| December 31, 2015 | -42.22M |
| September 30, 2015 | 30.51M |
| June 30, 2015 | -2.989M |
| March 31, 2015 | -28.79M |
| December 31, 2014 | 46.13M |
| September 30, 2014 | -63.69M |
| June 30, 2014 | 26.84M |
| March 31, 2014 | -272.67M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amarin Corp. Plc | 6.124M |
| Jazz Pharmaceuticals Plc | 354.90M |
| Prothena Corp. Plc | -0.6499M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Biogen, Inc. | -3.839B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 145.18M |
| Cash from Financing (Quarterly) | 17.20M |
| Free Cash Flow | 221.65M |
| Free Cash Flow Per Share (Quarterly) | 0.7899 |
| Free Cash Flow to Equity (Quarterly) | 146.13M |
| Free Cash Flow to Firm (Quarterly) | 130.11M |
| Free Cash Flow Yield | 2.74% |